Relief Therapeutics to get European patent for investigational drug RLF‑TD011
Hawkinsight
2025-02-11 18:03:06
2.25W
nicolas_
- Relief Therapeutics (OTCQB:RLFTY) Tuesday said that the European Patent Office has issued a Decision to Grant for its patent application titled \"Therapeutic Uses of Oxidizing Hypotonic Acid Solutions.\"
- This patent will protect therapeutic applications of Relief's (OTCQB:RLFTY) proprietary, highly pure
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
